Business and other management consultancy activities
K OG K AS
Revenue 2024
NOK 5.5m
Operating profit
NOK 4.2m
Equity
NOK 25.0m
Incorporated
2002
Share capital
NOK 3.5m
Roles
Daglig lederKari Grønås
Regnskapsfører
Styrets lederKjetil Hestdal
StyremedlemKari Grønås
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| KJETIL HESTDAL | 50.0% | 1.000000 | 2025 |
| KARI GRØNÅS | 50.0% | 1.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| CAEDO ONCOLOGY AS | Active | 10.5% | 17408.000000 |
| SERCA PHARMACEUTICALS AS | Active | 2.6% | 23385.000000 |
| AUGERE MEDICAL AS | Bankrupt | 0.9% | 3671.000000 |
| NOWWELL HOLDING AS | In liquidation | 0.6% | 1696.000000 |
| CALLUNA PHARMA POOLCO AS | Active | 0.2% | 61743.000000 |
| AXXELERATOR CAPITAL AS | Active | 0.1% | 5780.000000 |
| ONCOINVENT ASA | Active | 0.0% | 90201.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.